Early Initiation of Post Sternotomy CArdiac Rehabilitation

NCT ID: NCT03223558

Last Updated: 2021-05-05

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

158 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-07-10

Study Completion Date

2020-08-05

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The main objective of this trial is to investigate the effects of starting exercise rehabilitation earlier than current practice after coronary artery bypass graft(CABG) or Aortic/Mitral valve replacement (VR) surgery.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The trial will compare health improvements after cardiac rehabilitation, (CR) between participants randomly allocated to one of two groups: an early CR group starting exercise after 2 weeks, and a usual care group starting at 6 weeks. It will also collect information on the financial cost of earlier CR to both the health service and the patients.

All primary and secondary outcome measures will be taken at baseline (1 week) and repeated at the start and end of 8 weeks exercise rehabilitation program (2 and 10 weeks from baseline for the early group, 6 and 14 weeks in the usual care group respectively) and at 12 months follow-up.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Coronary Artery Disease Aortic Valve Disease Mitral Valve Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

A single blinded parallel group randomised controlled trial will be used to determine non-inferiority of early (2 weeks post operation) vs usual care (6 weeks post operation ) CR for a period of 8 weeks.
Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors
researchers will be blinded during baseline assessment prior to group allocation.

Participants and the clinical CR team will know the group allocation and therefore cannot be blinded. University hospitals for Coventry and Warwickshire NHS trust research and design department will generate the randomisation sequence remotely using permuted block randomisation.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

early rehab group

start of 8 weeks cardiac rehabilitation 2 weeks following surgery

Group Type EXPERIMENTAL

timing of initiation of cardiac rehabilitation

Intervention Type BEHAVIORAL

earlier timing of cardiac rehabilitation

usual care group

start 8 weeks of cardiac rehabilitation 6 weeks post surgery

Group Type ACTIVE_COMPARATOR

timing of initiation of cardiac rehabilitation

Intervention Type BEHAVIORAL

earlier timing of cardiac rehabilitation

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

timing of initiation of cardiac rehabilitation

earlier timing of cardiac rehabilitation

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Coronary artery bypass graft, and mitral/aortic valve replacement patients recovering from sternotomy procedure eligible for cardiac rehabilitation
* Able to provide written informed consent
* Male or female 18 years of age or greater

Exclusion Criteria

* Patients with any of the following:

* Serious cardiac arrhythmias
* Current neurological disorders or previous Cerebral Vascular Accident with residual neurological deficit significant enough to limit exercise
* Enrolled on another clinical trial that involved exercise
* Unable to enroll for duration of study
* Patients who are unable to provide written consent.
* Patients under the age of 18 or over the age of 90.
Minimum Eligible Age

18 Years

Maximum Eligible Age

90 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Coventry University

OTHER

Sponsor Role collaborator

University Hospitals Coventry and Warwickshire NHS Trust

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Stuart A Ennis

Role: PRINCIPAL_INVESTIGATOR

UHCW NHS trust

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

UHCW NHS trust

Coventry, West Midlands, United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United Kingdom

References

Explore related publications, articles, or registry entries linked to this study.

Ennis S, Lobley G, Worrall S, Evans B, Kimani PK, Khan A, Powell R, Banerjee P, Barker T, McGregor G. Effectiveness and Safety of Early Initiation of Poststernotomy Cardiac Rehabilitation Exercise Training: The SCAR Randomized Clinical Trial. JAMA Cardiol. 2022 Aug 1;7(8):817-824. doi: 10.1001/jamacardio.2022.1651.

Reference Type DERIVED
PMID: 35731506 (View on PubMed)

Ennis S, Lobley G, Worrall S, Powell R, Kimani PK, Khan AJ, Banerjee P, Barker T, McGregor G. Early initiation of post-sternotomy cardiac rehabilitation exercise training (SCAR): study protocol for a randomised controlled trial and economic evaluation. BMJ Open. 2018 Mar 23;8(3):e019748. doi: 10.1136/bmjopen-2017-019748.

Reference Type DERIVED
PMID: 29574443 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

SE191516

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.